BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32619609)

  • 1. Evaluating the structural effects of intra-articular sprifermin on cartilage and non-cartilaginous tissue alterations, based on sqMRI assessment over 2 years.
    Roemer FW; Kraines J; Aydemir A; Wax S; Hochberg MC; Crema MD; Guermazi A
    Osteoarthritis Cartilage; 2020 Sep; 28(9):1229-1234. PubMed ID: 32619609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial.
    Roemer FW; Aydemir A; Lohmander S; Crema MD; Marra MD; Muurahainen N; Felson DT; Eckstein F; Guermazi A
    BMC Musculoskelet Disord; 2016 Jul; 17():267. PubMed ID: 27393009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.
    Hochberg MC; Guermazi A; Guehring H; Aydemir A; Wax S; Fleuranceau-Morel P; Reinstrup Bihlet A; Byrjalsen I; Ragnar Andersen J; Eckstein F
    JAMA; 2019 Oct; 322(14):1360-1370. PubMed ID: 31593273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial.
    Eckstein F; Kraines JL; Aydemir A; Wirth W; Maschek S; Hochberg MC
    Ann Rheum Dis; 2020 Apr; 79(4):525-528. PubMed ID: 32098758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiquantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium.
    Collins JE; Losina E; Nevitt MC; Roemer FW; Guermazi A; Lynch JA; Katz JN; Kent Kwoh C; Kraus VB; Hunter DJ
    Arthritis Rheumatol; 2016 Oct; 68(10):2422-31. PubMed ID: 27111771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
    Lohmander LS; Hellot S; Dreher D; Krantz EF; Kruger DS; Guermazi A; Eckstein F
    Arthritis Rheumatol; 2014 Jul; 66(7):1820-31. PubMed ID: 24740822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief report: intraarticular sprifermin not only increases cartilage thickness, but also reduces cartilage loss: location-independent post hoc analysis using magnetic resonance imaging.
    Eckstein F; Wirth W; Guermazi A; Maschek S; Aydemir A
    Arthritis Rheumatol; 2015 Nov; 67(11):2916-22. PubMed ID: 26138203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-quantitative MRI biomarkers of knee osteoarthritis progression in the FNIH biomarkers consortium cohort - Methodologic aspects and definition of change.
    Roemer FW; Guermazi A; Collins JE; Losina E; Nevitt MC; Lynch JA; Katz JN; Kwoh CK; Kraus VB; Hunter DJ
    BMC Musculoskelet Disord; 2016 Nov; 17(1):466. PubMed ID: 27832771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.
    Eckstein F; Hochberg MC; Guehring H; Moreau F; Ona V; Bihlet AR; Byrjalsen I; Andersen JR; Daelken B; Guenther O; Ladel C; Michaelis M; Conaghan PG
    Ann Rheum Dis; 2021 Aug; 80(8):1062-1069. PubMed ID: 33962962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural effects of intra-articular TGF-β1 in moderate to advanced knee osteoarthritis: MRI-based assessment in a randomized controlled trial.
    Guermazi A; Kalsi G; Niu J; Crema MD; Copeland RO; Orlando A; Noh MJ; Roemer FW
    BMC Musculoskelet Disord; 2017 Nov; 18(1):461. PubMed ID: 29145839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline radiographic osteoarthritis and semi-quantitatively assessed meniscal damage and extrusion and cartilage damage on MRI is related to quantitatively defined cartilage thickness loss in knee osteoarthritis: the Multicenter Osteoarthritis Study.
    Guermazi A; Eckstein F; Hayashi D; Roemer FW; Wirth W; Yang T; Niu J; Sharma L; Nevitt MC; Lewis CE; Torner J; Felson DT
    Osteoarthritis Cartilage; 2015 Dec; 23(12):2191-2198. PubMed ID: 26162806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated MRI assessment confirms cartilage thickness modification in patients with knee osteoarthritis: post-hoc analysis from a phase II sprifermin study.
    Brett A; Bowes MA; Conaghan PG; Ladel C; Guehring H; Moreau F; Eckstein F
    Osteoarthritis Cartilage; 2020 Nov; 28(11):1432-1436. PubMed ID: 32860991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Magnetic Resonance Imaging-Based Definition of Knee Osteoarthritis: Data From the Multicenter Osteoarthritis Study.
    Liew JW; Rabasa G; LaValley M; Collins J; Stefanik J; Roemer FW; Guermazi A; Lewis CE; Nevitt M; Torner J; Felson D
    Arthritis Rheumatol; 2023 Jul; 75(7):1132-1138. PubMed ID: 36693143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial.
    Guehring H; Moreau F; Daelken B; Ladel C; Guenther O; Bihlet AR; Wirth W; Eckstein F; Hochberg M; Conaghan PG
    Semin Arthritis Rheum; 2021 Apr; 51(2):450-456. PubMed ID: 33752164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis.
    Dahlberg LE; Aydemir A; Muurahainen N; Gühring H; Fredberg Edebo H; Krarup-Jensen N; Ladel CH; Jurvelin JS
    Clin Exp Rheumatol; 2016; 34(3):445-50. PubMed ID: 27050139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Knee Effusion-synovitis and Joint Structural Changes in Patients with Knee Osteoarthritis.
    Wang X; Jin X; Blizzard L; Antony B; Han W; Zhu Z; Cicuttini F; Wluka AE; Winzenberg T; Jones G; Ding C
    J Rheumatol; 2017 Nov; 44(11):1644-1651. PubMed ID: 28864651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of MRI features for development of radiographic osteoarthritis in a cohort of participants with pre-radiographic knee osteoarthritis-the CHECK study.
    van Oudenaarde K; Jobke B; Oostveen AC; Marijnissen AC; Wolterbeek R; Wesseling J; Bierma-Zeinstra SM; Bloem HL; Reijnierse M; Kloppenburg M
    Rheumatology (Oxford); 2017 Jan; 56(1):113-120. PubMed ID: 28028160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What comes first? Multitissue involvement leading to radiographic osteoarthritis: magnetic resonance imaging-based trajectory analysis over four years in the osteoarthritis initiative.
    Roemer FW; Kwoh CK; Hannon MJ; Hunter DJ; Eckstein F; Fujii T; Boudreau RM; Guermazi A
    Arthritis Rheumatol; 2015 May; 67(8):2085-96. PubMed ID: 25940308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between suprapatellar pouch effusion-synovitis, serum cartilage oligomeric matrix protein, high sensitivity C-reaction protein, knee symptom, and joint structural changes in patients with knee osteoarthritis.
    Yang X; Ruan G; Xu J; Zheng S; Wang K; Ding C
    Clin Rheumatol; 2020 May; 39(5):1663-1670. PubMed ID: 31897961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of anatomical measures from MRI with radiographically defined knee osteoarthritis score, pain, and physical functioning.
    Sowers M; Karvonen-Gutierrez CA; Jacobson JA; Jiang Y; Yosef M
    J Bone Joint Surg Am; 2011 Feb; 93(3):241-51. PubMed ID: 21266638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.